World
AbbVie Secures Approval for EPKINLY in Combination With R2 as the First Bispecific Therapy for Relapsed or Refractory Follicular Lymphoma
EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available f...
November 19, 2025 | News
Thermo Fisher Opens Advanced Therapies Collaboration Center In Philadelphia To Accelerate Cell And Gene Therapy Development
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies ...
November 19, 2025 | News
Shanghai Henlius and Organon Achieve FDA Approval for POHERDY, First Pertuzumab Biosimilar in the US
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has approved the Biologics...
November 19, 2025 | News
Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...
November 19, 2025 | News
Thermo Fisher Scientific Enrolls First Patient in New CorEvitas™ Myasthenia Gravis Real-World Evidence Registry
Thermo Fisher Scientific Inc., the world leader in serving science, announced the enrollment of the first patient in the new PPD™ CorEvitas&tra...
November 18, 2025 | News
SAS Launches Clinical Acceleration to Modernise Clinical Trial Analytics and Speed Regulatory Submissions
Powered by the data and AI capabilities of SAS Viya, the life sciences solution streamlines drug development to deliver new therapies to patients faster&nb...
November 17, 2025 | News
Lupin Launches Risperidone Long Acting Injectable in the United States with PrecisionSphere Technology
Global pharma major Lupin announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 5...
November 17, 2025 | News
Strategic Transaction Positions Crown Bioscience for Global Expansion in Translational Oncology
Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology JSR Life Sciences, a global leader in life sci...
November 14, 2025 | News
IDT and Beckman Coulter Life Sciences Join Forces To Automate NGS Assays on the New Biomek i3 Platform
Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Beckman Coulter Life Sciences, a global leader in labo...
November 13, 2025 | News
Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...
November 13, 2025 | News
Utah’s Co-Diagnostics Expands Global Footprint with Saudi Joint Venture
Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a...
November 13, 2025 | News
Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry
The partnership brings together Medit's open, global digital platform and OraQ's advanced AI technologies to create new pathways for innovation and connect...
November 13, 2025 | News
Thermo Fisher Wins 510(k) Nod for EXENT System to Advance Myeloma Diagnosis
First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support ...
November 13, 2025 | News
SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...
November 12, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
